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Abstract
Figure 1: A-B. Schematic diagrams of the jump board strategy for engineering the let-7 locus. To generate the jump board
strain (A), hermaphrodites of the strain EG9615(oxSi1091[mex-5p::Cas9(smu-2 introns) unc-119(+)] II; unc-119(ed3) III)
carrying a transgene expressing the Cas9 protein were injected with a crRNA targeting let-7 (purple), tracrRNA and
dsDNA HDR donor to replace the 64 bp sequence corresponding to the precursor-let-7 transcript with the 23 bp jump
board sequence (blue). To permit recovery of F1 progeny carrying a lethal jump board let-7 null allele, injected P0
hermaphrodites were crossed to males carrying the mnDp1 [umnIs25] genetic balancer, which contains a wild type let-7
locus, as well as an integrated myo-2p::GFP transgene. The resulting jump board strain, VT3742(oxSi1091 II;
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mnDp1[umnIs25] (X;V)/+ V; let-7(ma393) X) was used as a platform for repeated mutagenesis at the let-7 locus. To use
the established jump board strain for mutagenesis (B), the let-7 jump board allele (ma393) in VT3742 was targeted by the
universal jump board guide INPP4A-crRNA and replaced by HDR with multiplexed dsDNA donors containing the let-7
locus with engineered mutations (red). The wild type allele of let-7 contained on mnDp1 is resistant to editing, since
INPP4A-crRNA is directed to the jump board sequence, permitting the recovery of lethal let-7 mutations complemented
by mnDp1. C. Screening strategy for (B) using EcoRV restriction analysis. After injection of VT3742, F1 animals with
mnDp1 balancer (detected by pharyngeal GFP) were collected after egg laying and subjected to PCR with flanking
primers, and the PCR products were digested by EcoRV. For F1 broods with no EcoRV cleavage (homozygous HDR or
homozygous InDel), the PCR products were subjected to Sanger sequencing to identify homozygous HDR lines. Note that
heterozygous HDR can also be identified by genotyping the F2 without mnDp1 followed by Sanger sequencing. However,
we have consistently observed that most F1 animals carrying HDR products were homozygous for the HDR alleles. D.
Summary of three mutageneses of let-7 locus using the jump board platform. Note that more F1 animals with co-CRISPR
phenotypes were isolated than were genotyped. E. Aligned sequences of wild type let-7, let-7(ma393), and examples of
let-7 alleles generated by replacement of jump board. Color schemes are consistent with (A-B). F. Aligned sequences of
the zinc finger region of lin-28 representing the application of jump board strategy for protein coding gene. The starting
strain VT3711(lin-28(ma416) I; maIs105 V) contains a lin-28 locus (ma416) expressing functional LIN-28 protein tagged
with 3xFLAG::6xHIS. The endogenous zinc finger domain (C144-C181, 114 bp) of lin-28 was targeted by two crRNAs in
Cas9 RNP and replaced with the jump board sequence using a ssDNA HDR donor. The resulting lin-28 jump board allele
lin-28(ma416ma487) had severe heterochronic phenotypes (including sterility) and was then crossed with lin-46(ma164),
a genetic suppressor of lin-28(lf), to produce the jump board targeting strain, VT3914(lin-28(ma416ma487) I; lin-
46(ma164) V) (Pepper et al., 2004). The lin-28 jump board allele (ma487) was subsequently targeted by INPP4A-crRNA
and a dsDNA HR donor with 35/35 bp homology to replace ma487 with a lin-28 locus carrying a compound mutation
(ma514) in which 8 critical amino acid residues of the two zinc fingers were replaced by alanine residues. The numbers
indicate the positions at chr. I according to Wormbase WS277.
Description
The application of CRISPR/Cas9 genome editing has revolutionized the genetic analysis of gene function in vivo by
enabling highly efficient and precise in loco mutagenesis of defined genomic loci (Adli, 2018). In particular,
CRISPR/Cas9 mediated homologous directed recombination (HDR) permits the introduction of complex genetic
modifications at single nucleotide resolution (Cong et al., 2013; Dickinson et al., 2013). However, the targeted
mutagenesis of essential genes using CRISPR/Cas9 can be challenging since the recovery of deleterious mutations of an
essential gene may require a genetic balancer with a wild type copy of the gene (or alternatively a genetic suppressor
locus) that can be later outcrossed for phenotypic analysis of novel targeted mutations. Genetic balancers are commonly
available for model organisms such as worms or flies, but in the context of CRISPR/Cas9 genome editing, the balancer
itself can be edited along with the targeted genomic locus, dramatically reduce the efficiency of recovering the desired loss
of function alleles. Therefore, editing of essential genes would be facilitated by a strategy where the targeted genomic
locus is efficiently edited, whilst the balancer locus is resistant to editing.
Here, we describe a platformed “jump board” strategy and its application in systematically engineering the essential
microRNA let-7 (Fig. 1A-E) and protein coding gene lin-28 (Fig. 1F) in C. elegans. We chose the jump board protospacer
sequence (INPP4A) which is (1) comprised of a PAM site and a protospacer antisense to a crRNA with experimentally
confirmed high editing efficiency (INPP4A-crRNA), and (2) non-homologous to C. elegans genome, including the genetic
balancer we used (mnDp1). Notably, the jump board protospacer contains an EcoRV restriction site, which can be utilized
for rapid large-scale genotyping by which HDR events can be identified in the F1 generation (Fig. 1C). Using the jump
board strategy, we have so far created 28 let-7 alleles for various experimental purposes, among which 15 alleles showed
lethality and require rescue by mnDp1. Note that the let-7 jump board allele (ma393) itself is a new let-7 null allele in
which the precursor-let-7 is completely removed.
We have also used the jump board strategy to mutate the two CCHC motifs at the zinc finger domain of lin-28 (Fig. 1F)
(Mayr and Heinemann, 2013; Van Wynsberghe et al., 2011). lin-28(lf) phenotypes include near-sterility, which could have
been mitigated by using a genetic balancer for chromosome I (analogous to the approach for let-7), but in this case we
employed a lin-46(lf) genetic background which suppresses lin-28(lf) phenotypes (Pepper et al., 2004). We suggest that
lin-28 represents an example of how the jump board strategy offers significant advantages for systematic mutagenesis of
protein coding genes, as well as microRNAs or other non-coding sequences.
The jump board strategy described here can facilitate the targeted mutagenesis at essential genes for a number of reasons:
1) for genetic loci that lack convenient and efficient protospacer sites, the jump board provides a highly efficient foreign
crRNA/protospacer platform; 2) the jump board protospacer sequence contains a convenient restriction site that facilitates
rapid large-scale genotyping; 3) the targeting of a foreign sequence protospacer enables the use of genetic balancers
unconfounded by undesired editing of the balancers. Conventionally, essential genes can also be edited by targeting the
wild type locus, and employing a balancer to rescue the mutations, either by crossing the P0s with balancer-carrying
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males, or by including the balancer from the outset. In the first instance, the jump board strategy eliminates the need to
cross the P0s, and in the second instance, the fact that only the jump board sequence is targeted eliminates the
complications associated with unwanted editing of the balancer, which include loss of homozygous edited F1s, and extra
crossing step and/or genotyping to distinguish balancer edits from chromosomal edits. We thus suggest that the jump
board strategy, although requiring an extra step to establish the platform, offers particular advantages for repeated
mutagenesis of individual loci of interest, where throughput is promoted by the highly efficient INPP4A protospacer and
the ease of screening for desired edits. We also note that the jump board strategy also prevents cleavage of dsDNA HDR
donor molecules or re-cleavage of converted loci, both of which can impact HDR efficiency. Finally, C. elegans gene
editing technology using CRISPR continues to improve through innovation, for example, to the design of donors and the
compositions and preparation of reagent mixtures (Dokshin et al., 2018; Ghanta and Mello, 2020; Richardson et al., 2016;
Song et al., 2016). These improvements can be applied to the jump board HDR approach for even greater throughput of
targeted mutagenesis.
Methods
Request a detailed protocol
Genome editing at the let-7 genomic locus
Sequences corresponding to the WT precursor-let-7 and its 500 bp flanking regions were cloned into pCR2.1-TOPO
vector. The Q5 mutagenesis kit (NEB, Cat:E0554) was used to generate the mutant plasmids. dsDNA donors were
generated from the mutagenized plasmids by PCR with 73/106 bp flanking the precursor-let-7 and purified by ethanol
precipitation. Injection mixtures containing final concentrations of 30 ng/µl AltR_Cas-9_crRNA_let-7 (step 1) or
AltR_Cas-9_crRNA_INPP4A (step 2) (PAM sites shown in Fig. 1D), 10 ng/µl AltR_Cas-9_crRNA_dpy-10_cn64 as co-
CRISPR marker (Arribere et al., 2014), 75 ng/µl Alt-R tracrRNA (IDT, Cat:1072532), 10 ng/µl each dsDNA donor and
1X duplex buffer (IDT, Cat: 11010301) were incubated at room temperature for 10 min for pre-annealing and injected into
the gonad of young adults of strain EG9615(oxSi1091[mex-5p::Cas-9(smu-2 introns) unc-119(+)] II; unc-119(ed3) III)
(step 1) or VT3742(oxSi1091 II; mnDp1[umnIs25] (X;V)/+ V; let-7(ma393) X) (step 2). We suggest injecting 4-8 P0 for
single HDR donor and 8-16 P0 for multiplexed HDR donors.
Genotyping the products of HDR at the let-7 locus
For both steps (Fig. 1A and B), F1 dumpy/roller animals with mnDp1[umnIs25] (detected by pharyngeal GFP) were
picked and genotyped by PCR after egg laying, and the PCR products were analyzed by restriction digestion using EcoRV
(NEB, Cat:R3195S) at 1 unit/µl PCR product for 30 min. In the first step (Fig. 1A), samples from the broods with jump
board HDR should have EcoRV cleavage. In the second step (Fig. 1B), samples containing either homozygous HDR or
homozygous InDel should have no EcoRV cleavage. Samples with candidate HDR (with EcoRV cleavage in Fig. 1A and
with no EcoRV cleavage in Fig. 1B) were subjected to Sanger sequencing, and F1 broods with homozygous HDR were
selected and outcrossed. For the genotype screen at the second step, we suggest screening 48 F1 for single HDR donor and
96 F1 for multiplexed HDR donors.
Genome editing and genotyping at the lin-28 genomic locus
In the first step of editing, the Ultramer single-strand DNA donor with 35/35 nt flanking homology was obtained from
IDT. The injection mixture containing final concentrations of 15.3 ng/µl AltR_Cas-9_crRNA_lin-28_1, 15.1 ng/µl
AltR_Cas-9_crRNA_lin-28_2 (PAM sites shown in Fig. 1F), 7.2 ng/µl AltR_Cas-9_crRNA_dpy-10_cn64, 82.6 ng/µl Alt-
R tracrRNA, 159.1 ng/µl ssDNA donor, 0.57 ng/µl AltR-S.p.Cas9 nuclease (IDT, Cat: 1081058) and 1X duplex buffer
were incubated at 4 °C for 15 min for pre-annealing and injected into VT3711(lin-28(ma416) I; maIs105 V) at young adult
stage. F1 dumpy animals were picked and genotyped by PCR (after egg laying) using flanking primers, and samples with
PCR products of the expected (reduced) size were confirmed by Sanger sequencing.
In the second step of editing, dsDNA HDR donors were generated with 35/35 bp flanking homology following a protocol
analogous to that for the let-7 locus. Injection mixture containing final concentrations of 30.7 ng/µl AltR_Cas-
9_crRNA_INPP4A, 7.2 ng/µl AltR_Cas-9_crRNA_dpy-10_cn64, 82.6 ng/µl Alt-R tracrRNA, 108 ng/µl dsDNA donor,
0.57 ng/µl AltR-S.p.Cas9 nuclease and 1X duplex buffer were incubated at 4 °C for 15 min for pre-annealing and injected
into the gonad of VT3914(lin-28(ma416ma487) I; lin-46(ma164) V) at the young adult stage. Genotyping was performed
using PCR, EcoRV digestion, and Sanger sequencing, as described above.
Reagents
VT3742(oxSi1091 II; mnDp1[umnIs25] (X;V)/+ V; let-7(ma393) X), VT3914(lin-28(ma416ma487) I;lin-46(ma164) V)
strains and oligo sequences are available upon request.
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